U.S. Non-Hodgkin Lymphoma Drug Market Trends: Immunotherapy and...

agregó una foto Home

2025-07-18 12:16:51 - Translate

U.S. Non-Hodgkin Lymphoma Drug Market Trends: Immunotherapy and Biosimilar Adoption

The global non-Hodgkin lymphoma (NHL) therapeutics market, valued at USD 9.05 billion in 2024, is projected to grow at a CAGR of 7.7% from 2025 to 2034. This growth is being shaped by the strategic positioning of key countries and leading pharmaceutical players, with the United States, Germany, China, and Japan emerging as pivotal contributors to market expansion. These nations are leveraging...

0 Commentarios 0 Acciones 99 Views 0 Vista previa